Elevation of tau protein levels in the cerebrospinal fluid of children with West syndrome

Epilepsy Research

Volumn 102, Issue 1-2, 2012, Pages 8-12

  Inoue, Hirofumi ^a   Matsushige, Takeshi ^a   Hasegawa, Shunji ^a   Abe, Arisa ^a   Iida, Yasunori ^a   Inoue, Teruaki ^a   Ichiyama, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenocorticotropic hormone; Cerebrospinal fluid; Tau protein; West syndrome

Indexed keywords

CORTICOTROPIN; PYRIDOXINE; TAU PROTEIN; VALPROIC ACID; VIGABATRIN;

CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; NERVE INJURY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; REVIEW; SYMPTOMATOLOGY; TREATMENT RESPONSE; WEST SYNDROME;

ADRENOCORTICOTROPIC HORMONE; AXONS; CHILD, PRESCHOOL; FEMALE; HORMONES; HUMANS; INFANT; MALE; NERVE DEGENERATION; SPASMS, INFANTILE; TAU PROTEINS;

EID: 84868302632     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.07.002     Document Type: Review

References (18)

1. Baram T.Z., Hatalski C.G. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci. 1998, 21:471-476.
2. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol. Chem. Neuropathol. 1995, 26:231-245.
3. Brunson K.L., Khan N., Eghbal-Ahmadi M., Baram T.Z. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann. Neurol. 2001, 49:304-312.
4. de Bont J.M., Vanderstichele H., Reddingius R.E., Pieters R., van Gool S.W. Increased total-tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients. Pediatr. Neurol. 2008, 12:334-341.
5. Delacourte A. Pathological tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration. Biomed. Pharmacother. 1994, 48:287-295.
6. Gorath M., Stahnke T., Mronga T., Goldbaum O., Richeter-Landsberg C. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 2001, 36:89-101.
7. Hamano S., Yoshinari S., Higurashi N., Tanaka M., Minamitani M., Eto Y. Regional cerebral blood flow and developmental outcome in cryptogenic West syndrome. Epilepsia 2007, 48:114-119.
8. Hesse C., Rosengren L., Vanmechelen E., Vanderstichele H., Jensen C., Davidsson P., Blennow K. Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. J. Alzheimers Dis. 2000, 2:199-206.
9. Ito M. Extremely low-dose ACTH therapy for West syndrome in Japan. Brain Dev. 2001, 23:635-641.
10. Kivity S., Lerman P., Ariel R., Danziger Y., Mimouni M., Shinnar S. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004, 45:255-262.
11. Mandelkow E.M., Biernat J., Drewes G., Gutske N., Trinczek B., Mandelkow E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging 1995, 16:355-363.
12. öst M., Nylén K., Csajbok L., Ohrfelt A.O., Tullberg M., Wikkelsö C., Nellgård P., Rosengren L., Blennow K., Nellgård B. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006, 67:1600-1604.
13. Palmio J., Suhonen J., Keränen T., Hulkkonen J., Peltola J., Pirttilä T. Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure. Seizure 2009, 18:474-477.
14. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996, 37:367-372.
15. Süssmuth S.D., Reiber H., Tumani H. Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci. Lett. 2001, 300:95-98.
16. Tanuma N., Miyata R., Kumada S., Kubota M., Takanashi J., Okumura A., Hamano S., Hayashi M. The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev. 2010, 32:435-439.
17. Yan X.X., Toth Z., Schultz L., Ribak C.E., Baram T.Z. Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus 1998, 8:231-243.
18. You Y., Bai H., Wang C., Chen L.W., Liu B., Zhang H., Gao G.D. Myelin damage of hippocampus and cerebral cortex in rat pentylenetetrazol model. Brain Res. 2011, 1381:208-216.